News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

KaloBios Pharmaceuticals, Inc. Reports Third Quarter 2013 Financial Results



11/12/2013 9:50:40 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

SOUTH SAN FRANCISCO, Calif., Nov. 12, 2013 /PRNewswire/ -- KaloBios Pharmaceuticals, Inc. (KBIO) a biopharmaceutical company with a portfolio of patient-targeted, first-in-class, monoclonal antibodies (mAbs) to treat severe respiratory diseases and cancer, announced today its corporate highlights and financial results for the third quarter ending September 30, 2013.

Help employers find you! Check out all the jobs and post your resume.

Read at Yahoo Finance


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES